1887

oa South African Medical Journal - Clinical evaluation of indoramin as the sole agent for the treatment of hypertension

 

Abstract

An open-ended clinical trial of Indoramin (WY-21901), a new antihypertensive agent with both a-adrenergic blocking and cardio-inhibitory properties, was conducted on a group of 27 patients with mild or moderate essential hypertension.

Loading

Article metrics loading...

/content/m_samj/48/37/AJA20785135_27235
1974-08-01
2016-12-06
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error